Literature DB >> 11491036

Meeting the challenge of tobacco use within the Medicaid population.

R M Carr1, B Christiansen, L Jehn, D Matitz.   

Abstract

The Wisconsin Medicaid Program, which purchases health care for Wisconsin's low income residents, has entered into a number of partnerships designed to systematically address tobacco use by Medicaid recipients. With the help of Wisconsin HMOs, a chart audit established an overall tobacco use prevalence of 45.7%, about double that of the general population. A direct survey of Medicaid recipients confirmed a rate of 45.0%. The chart audit also revealed a dramatic under-utilization of currently available Medicaid smoking cessation benefits. Plans are now being made to increase this utilization on a statewide basis. In addition, a partnership with the Wisconsin Women's Health Foundation and the Bureau of Family and Community Health Program within the Division of Public Health has resulted in a pilot project to address tobacco use by low income, pregnant women. Finally, a partnership with a specialized HMO serving those with disabilities and the Mental Health Association in Milwaukee County plans to address tobacco use by those with chronic and persistent mental illness.

Entities:  

Mesh:

Year:  2001        PMID: 11491036

Source DB:  PubMed          Journal:  WMJ        ISSN: 1098-1861


  3 in total

1.  The uninsured and Medicaid Oregon tobacco user experience in a real world, phone based cessation programme.

Authors:  Ay El-Bastawissi; T McAfee; S M Zbikowski; J Hollis; M Stark; K Wassum; N Clark; R Barwinski; E Broughton
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

2.  Medicaid reimbursement for prenatal smoking intervention influences quitting and cessation.

Authors:  R Petersen; J M Garrett; C L Melvin; K E Hartmann
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

3.  Factors associated with physician interventions to address adolescent smoking.

Authors:  Tammy H Sims; John R Meurer; Mario Sims; Peter M Layde
Journal:  Health Serv Res       Date:  2004-06       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.